US 9315813
Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
granted A61PA61P1/16A61P3/06
Quick answer
US patent 9315813 (Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/16, A61P3/06, A61P43/00